{"DataElement":{"publicId":"3135548","version":"1","preferredName":"Disease or Disorder International Prognostic Scoring System (IPSS) for Myelodysplastic Syndromes Prognosis Score","preferredDefinition":"Numeric rating of the International Prognostic Scoring System for myelodysplastic syndromes score.","longName":"3135536v1.0:3135542v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3135536","version":"1","preferredName":"Disease or Disorder International Prognostic Scoring System (IPSS) for Myelodysplastic Syndromes Prognosis","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A system for scoring myelodysplasia syndrome progression risk, based on a combination of: percentage of blast cells in the bone marrow, the presence and severity of specific cytogenetic abnormalities, and the number of cytopenias in the peripheral blood._The likely outcome or course of a disease; the chance of recovery or recurrence.","longName":"2404658v1.0:3135534v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3135534","version":"1","preferredName":"International Prognostic Scoring System (IPSS) for Myelodysplastic Syndromes Prognosis","preferredDefinition":"A system for scoring myelodysplasia syndrome progression risk, based on a combination of: percentage of blast cells in the bone marrow, the presence and severity of specific cytogenetic abnormalities, and the number of cytopenias in the peripheral blood.:(prog-NO-sis) The likely outcome or course of a disease; the chance of recovery or recurrence.","longName":"C84350:C17013","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Prognostic Scoring System (IPSS) for Myelodysplastic Syndromes","conceptCode":"C84350","definition":"A system for scoring myelodysplasia syndrome progression risk, based on a combination of: percentage of blast cells in the bone marrow, the presence and severity of specific cytogenetic abnormalities, and the number of cytopenias in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prognosis","conceptCode":"C17013","definition":"Prediction of the probable course and outcome of a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD37F83-98A9-AFE4-E040-BB89AD4316C9","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2010-09-09","modifiedBy":"ONEDATA","dateModified":"2010-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD37F83-98BA-AFE4-E040-BB89AD4316C9","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2010-09-09","modifiedBy":"NYCHM","dateModified":"2017-03-01","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3135542","version":"1","preferredName":"International Prognostic Scoring System (IPSS) for Myelodysplastic Syndromes Score","preferredDefinition":"A system for scoring myelodysplasia syndrome progression risk, based on a combination of: percentage of blast cells in the bone marrow, the presence and severity of specific cytogenetic abnormalities, and the number of cytopenias in the peripheral blood._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"3135542v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"3.5","valueDescription":"IPSS score 3.5","ValueMeaning":{"publicId":"4746863","version":"1","preferredName":"IPSS score 3.5","longName":"4746863","preferredDefinition":"Percent blasts: 20-30%; Karyotype: Poor (complex, chrom 7 abnormalities); Cytopenias: 2-3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11917267-AC18-5CF2-E050-BB89AD437299","latestVersionIndicator":"Yes","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11917267-AC31-5CF2-E050-BB89AD437299","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"ONEDATA","dateModified":"2015-03-18","deletedIndicator":"No"},{"value":"3.0","valueDescription":"IPSS score 3.0","ValueMeaning":{"publicId":"4746864","version":"1","preferredName":"IPSS score 3.0","longName":"4746864","preferredDefinition":"Consists of 3 possible IPSS scores:\r\n1) Percent blasts: 20-30%; Karyotype: Poor (complex, chrom 7 abnormalities); Cytopenias: 0-1\r\n2) Percent blasts: 20-30%; Karyotype: Intermediate (other abnormalities); Cytopenias: 2-3\r\n3) Percent blasts: 11-20%; Karyotype: Poor (complex, chrom 7 abnormalities); Cytopenias: 2-3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11917267-AC3B-5CF2-E050-BB89AD437299","latestVersionIndicator":"Yes","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11917267-AC54-5CF2-E050-BB89AD437299","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"ONEDATA","dateModified":"2015-03-18","deletedIndicator":"No"},{"value":"2.5","valueDescription":"IPSS score 2.5","ValueMeaning":{"publicId":"4746865","version":"1","preferredName":"IPSS score 2.5","longName":"4746865","preferredDefinition":"Consists of 4 possible IPSS scores:\r\n1) Percent blasts: 20-30%; Karyotype: Good (normal, -Y, del(5q), del(20q)); Cytopenias: 2-3\r\n2) Percent blasts: 20-30%; Karyotype: Intermediate (other abnormalities); Cytopenias: 0-1\r\n3) Percent blasts: 11-20%; Karyotype: Poor (complex, chrom 7 abnormalities); Cytopenias: 0-1\r\n4) Percent blasts: 11-20; Karyotype: Intermediate (other abnormalities); Cytopenias: 2-3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11917267-AC5E-5CF2-E050-BB89AD437299","latestVersionIndicator":"Yes","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11917267-AC77-5CF2-E050-BB89AD437299","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"ONEDATA","dateModified":"2015-03-18","deletedIndicator":"No"},{"value":"0.0","valueDescription":"IPSS score 0.0","ValueMeaning":{"publicId":"4746866","version":"1","preferredName":"IPSS score 0.0","longName":"4746866","preferredDefinition":"Percent blasts: <5% \r\nKaryotype: Good (normal, -Y, del(5q), del(20q)); \r\nCytopenias: 0-1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11917267-AC81-5CF2-E050-BB89AD437299","latestVersionIndicator":"Yes","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11917267-AC99-5CF2-E050-BB89AD437299","beginDate":"2010-09-09","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"ONEDATA","dateModified":"2015-03-18","deletedIndicator":"No"},{"value":"0.5","valueDescription":"IPSS score 0.5","ValueMeaning":{"publicId":"4746867","version":"1","preferredName":"IPSS score 0.5","longName":"4746867","preferredDefinition":"Consists of 3 possible IPSS scores:\r\n1) Percent blasts: 5 - 10%; Karyotype: Good (normal, -Y, del(5q), del(20q)); Cytopenias: 0.1\r\n2) Percent blasts: <5%;  Karyotype: Intermediate (other abnormalities); Cytopenias: 0-1\r\n3) Percent blasts: <5%;  Karyotype: Good (normal, -Y, del(5q), del(20q); Cytopenias: 2-3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11917267-ACA3-5CF2-E050-BB89AD437299","latestVersionIndicator":"Yes","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11917267-ACBB-5CF2-E050-BB89AD437299","beginDate":"2010-09-09","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"ONEDATA","dateModified":"2015-03-18","deletedIndicator":"No"},{"value":"1.0","valueDescription":"IPSS score 1.0","ValueMeaning":{"publicId":"4746868","version":"1","preferredName":"IPSS score 1.0","longName":"4746868","preferredDefinition":"Consists of 4 possible IPSS scores:\r\n1) Percent blasts: <5%; Karyotype: Poor (complex, chrom 7 abnormalities); Cytopenias: 0-1\r\n2) Percent blasts: 5-10%; Karyotype: Intermediate (other abnormalities); Cytopenias: 0-1\r\n3) Percent blasts: <5-10%; Karyotype: Good (normal, -Y, del(5q), del(20q)); Cytopenias: 2-3\r\n4) Percent blasts: <5; Karyotype: Intermediate (other abnormalities); Cytopenias: 2-3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11917267-ACC5-5CF2-E050-BB89AD437299","latestVersionIndicator":"Yes","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11917267-ACDD-5CF2-E050-BB89AD437299","beginDate":"2010-09-09","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"ONEDATA","dateModified":"2015-03-18","deletedIndicator":"No"},{"value":"1.5","valueDescription":"IPSS score 1.5","ValueMeaning":{"publicId":"4746869","version":"1","preferredName":"IPSS score 1.5","longName":"4746869","preferredDefinition":"Consists of 4 possible IPSS scores:\r\n1) Percent blasts: 11-20%; Karyotype: Good (normal, -Y, del(5q), del(20q)); Cytopenias: 0-1\r\n2) Percent blasts: 5-10%; Karyotype: Intermediate (other abnormalities); Cytopenias: 2-3\r\n3) Percent blasts: <5-10%; Karyotype: Poor (complex, chrom 7 abnormalities); Cytopenias: 0-1\r\n4) Percent blasts: <5; Karyotype: Poor (complex, chrom 7 abnormalities); Cytopenias: 2-3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11917267-ACE7-5CF2-E050-BB89AD437299","latestVersionIndicator":"Yes","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11917267-ACFF-5CF2-E050-BB89AD437299","beginDate":"2010-09-09","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"ONEDATA","dateModified":"2015-03-18","deletedIndicator":"No"},{"value":"2.0","valueDescription":"IPSS score 2.0","ValueMeaning":{"publicId":"4746870","version":"1","preferredName":"IPSS score 2.0","longName":"4746870","preferredDefinition":"Consists of 4 possible IPSS scores:\r\n1) Percent blasts: 20-30%; Karyotype: Good (normal, -Y, del(5q), del(20q)); Cytopenias: 0.1\r\n2) Percent blasts: 11-20%; Karyotype: Intermediate (other abnormalities); Cytopenias: 0-1\r\n3) Percent blasts: 11-20%; Karyotype: Good (normal, -Y, del(5q), del(20q)); Cytopenias: 2-3\r\n4) Percent blasts: 5-10; Karyotype: Poor (complex, chrom 7 abnormalities); Cytopenias: 2-3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11917267-AD09-5CF2-E050-BB89AD437299","latestVersionIndicator":"Yes","beginDate":"2015-03-18","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"11917267-AD21-5CF2-E050-BB89AD437299","beginDate":"2010-09-09","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-03-18","modifiedBy":"ONEDATA","dateModified":"2015-03-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4715416","version":"1","preferredName":"International Prognostic Scoring System (IPSS) for Myelodysplastic Syndromes Score","preferredDefinition":"A system for scoring myelodysplasia syndrome progression risk, based on a combination of: percentage of blast cells in the bone marrow, the presence and severity of specific cytogenetic abnormalities, and the number of cytopenias in the peripheral blood.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C84350:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Prognostic Scoring System (IPSS) for Myelodysplastic Syndromes","conceptCode":"C84350","definition":"A system for scoring myelodysplasia syndrome progression risk, based on a combination of: percentage of blast cells in the bone marrow, the presence and severity of specific cytogenetic abnormalities, and the number of cytopenias in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0ED35269-92A9-4F20-E050-BB89AD4365D1","latestVersionIndicator":"Yes","beginDate":"2015-02-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-02-11","modifiedBy":"ONEDATA","dateModified":"2015-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD5F02A-00A5-02F9-E040-BB89AD431283","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":null,"createdBy":"SORENSENS","dateCreated":"2010-09-09","modifiedBy":"NYCHM","dateModified":"2017-03-01","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964931","version":"1","longName":"2014r1: MDS Pre-HSCT Data","context":"NHLBI"}]}],"AlternateNames":[{"name":"mds_base_mds_prognsis_scr","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the International Pr","type":"Preferred Question Text","description":"What was the International Prognostic Scoring System for myelodysplastic syndromes score?","url":null,"context":"NHLBI"},{"name":"What was the disease prognosis score?","type":"Alternate Question Text","description":"What was the disease prognosis score?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FD5F02A-0171-02F9-E040-BB89AD431283","latestVersionIndicator":"Yes","beginDate":"2010-09-09","endDate":"2014-04-15","createdBy":"SORENSENS","dateCreated":"2010-09-09","modifiedBy":"NYCHM","dateModified":"2017-03-01","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}